Pr. Alain Puisieux - Biography

Following his Pharmacy internship in Paris (France) and a fellowship at the Massachusetts General Hospital, Harvard Medical School, Boston (United States, 1989-1991), during which he investigated the molecular mechanisms of hepatocarcinogenesis, Alain Puisieux joined the Léon Bérard Cancer Centre in Lyon (France) in 1997. There, he created the Molecular Oncology Laboratory before being promoted Professor in Biochemistry and Cellular Biology at the Claude Bernard University in 1999. Alain Puisieux was head of the U590 Inserm unit “Oncogenesis and tumoral progression” from 2003 to 2010. In January 2011, he created the Cancer Research Center of Lyon (CRCL), currently encompassing 24 research teams or 480 staff members, and became its director for two consecutive mandates (2011-2020). His scientific team focuses its work on the role of EMT-inducing transcription factors in cancer cell plasticity and intra-tumor heterogeneity. He was awarded several prestigious prizes, including the Ruban Rose prize (breast cancer research) in 2018, the Dandrimont et Bénicourt prize from the National Academy of Sciences in 2017, the Charles Oberling prize in 2016, the European Association for Cancer Research Proffered Paper Award in 2012 and the Raymond Rosen prize from the Medical Research Foundation in 2009. Alain Puisieux is Chevalier de l’Ordre des Palmes Académiques, he is a member of the French National Academy of Medicine, a member of the French National Academy of Pharmacy and a former member of the Institut Universitaire de France.

CENTRE DE RECHERCHE EN CANCEROLOGIE DE LYON (CRCL)
UMR INSERM 1052 CNRS 5286 - CENTRE LEON BERARD
Copyright 2011. CRCL
SUIVEZ LES ACTUALITES
DU CRCL SUR TWITTER :